Gunthorpe Martin

Biography

  Mr. Martin Gunthorpe, Ph.D. has been Chief Scientific Officer at BioCrea GmbH since joining in 2010. Mr. Gunthorpe served as Head of Electrophysiology in the Neurosciences Centre of Excellence for Drug Discovery at GSK and the leader of a GSK spinout company. Mr. Gunthorpe has wide-ranging experience of the development of innovative therapeutics, particularly in the neurosciences therapeutic area and ion channel target class. He has an excellent track record of successfully leading multidisciplinary preclinical and clinical project teams to deliver drug candidates into early clinical development and has late-stage experience from contributions to the approval and launch of retigabine as a first-in-class treatment for epilepsy. He has extensive experience of licensing with multiple successful deals completed for pharma and biotech  

Research Interest

 clinical science